Phase I/IIa Study for PM1032 in the Treatment of Patients With Advanced Solid Tumors

NCT05839106 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

UNKNOWN

Status

200

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Tumor

Interventions

DRUG: PM1032 injection

Sponsor

Biotheus Inc.